changed my mind on this, i started thinking amylin was the interesting bit and now i think its the pairing, thats just me
#cagrilintide 2026-04-15
- area_percent — amylin is co-secreted with insulin from beta cells. it slows gastric emptying and signals satiety centrally 11:30
- taper_tess — the same door analogy is what finally made this click for me two years ago 11:33
- area_percent — which fits the mechanism reasonably well. amylin acting on gastric emptying and hindbrain satiety pathways 11:41
- ivy_injects — minutes to a week is a hell of a bit of engineering 14:16
- taper_tess — standing rule and it keeps needing saying 15:34
the nausea felt different rather than less, more fullness and less of the queasy wave
monotherapy here
genuine question i titrated over twice as many weeks as i did on semaglutide and that was right for me
thats the phase 3 one
noticed something around week 32 on monotherapy, well after i had given up expecting to, your mileage will differ
dosing them on different days made no difference i could detect, still working it out
cagrisema thats it
cant separate them
i keep seeing cagri described as a GLP-1. it isnt is it
no. amylin analogue. completely different peptide family and a different set of receptors
amylin is co-secreted with insulin from beta cells. it slows gastric emptying and signals satiety centrally
that sounds like the same job
same outcome, different door. thats exactly why combining them is interesting
the same door analogy is what finally made this click for me two years ago
the practical difference for me was the flavour of the side effects
sema nausea was a wave. cagri was more like being uncomfortably full all the time
which is worse
the full feeling is easier to work around and harder to ignore. i genuinely dont know which is worse
mine matched that. less queasy, more early satiety. i put my fork down mid meal without deciding to
which fits the mechanism reasonably well. amylin acting on gastric emptying and hindbrain satiety pathways
monotherapy weight loss in that trial was real but modest next to what sema was doing at the time
so its a weaker drug
weaker alone. thats not the same as less useful
and thats the argument that runs all week in here, so grab a seat
worth knowing the half-life is long, roughly weekly, so its a once a week injection like the others
yes, engineered for weekly. native amylin has a half-life of minutes
minutes to a week is a hell of a bit of engineering
acylation and sequence changes. same general trick as the GLP-1 analogues, different starting peptide
the older one people bring up is pramlintide, which was three injections a day with meals
and thats why nobody used it
thats a large part of why, yes
does the titration work the same way
slower in my experience. see the conversation below, thats the whole other argument
your fullness vs wave description — has anyone had both at once on the combo
yes and it was a lot in month one. it settled. i would not want to relive weeks two to four though
and if it does not settle, that is a doctor conversation rather than a hold the dose conversation
standing rule and it keeps needing saying